Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 3
1981 3
1982 1
1983 3
1984 4
1985 10
1986 7
1987 5
1988 9
1989 4
1990 13
1991 5
1992 4
1993 3
1994 5
1995 5
1996 6
1997 7
1998 8
1999 8
2000 11
2001 17
2002 8
2003 7
2004 7
2005 9
2006 14
2007 11
2008 9
2009 8
2010 11
2011 19
2012 14
2013 11
2014 18
2015 17
2016 19
2017 16
2018 10
2019 10
2020 11
2021 11
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

363 results
Results by year
Filters applied: . Clear all
Page 1
[Skin aging: Pathophysiology and innovative therapies].
Boismal F, Serror K, Dobos G, Zuelgaray E, Bensussan A, Michel L. Boismal F, et al. Among authors: bensussan a. Med Sci (Paris). 2020 Dec;36(12):1163-1172. doi: 10.1051/medsci/2020232. Epub 2020 Dec 9. Med Sci (Paris). 2020. PMID: 33296633 Free article. Review. French.
Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies.
Perrot I, Michaud HA, Giraudon-Paoli M, Augier S, Docquier A, Gros L, Courtois R, Déjou C, Jecko D, Becquart O, Rispaud-Blanc H, Gauthier L, Rossi B, Chanteux S, Gourdin N, Amigues B, Roussel A, Bensussan A, Eliaou JF, Bastid J, Romagné F, Morel Y, Narni-Mancinelli E, Vivier E, Paturel C, Bonnefoy N. Perrot I, et al. Among authors: bensussan a. Cell Rep. 2019 May 21;27(8):2411-2425.e9. doi: 10.1016/j.celrep.2019.04.091. Cell Rep. 2019. PMID: 31116985 Free article.
ENTPD1/CD39 is a promising therapeutic target in oncology.
Bastid J, Cottalorda-Regairaz A, Alberici G, Bonnefoy N, Eliaou JF, Bensussan A. Bastid J, et al. Among authors: bensussan a. Oncogene. 2013 Apr 4;32(14):1743-51. doi: 10.1038/onc.2012.269. Epub 2012 Jul 2. Oncogene. 2013. PMID: 22751118 Review.
Up-and-down immunity of pregnancy in humans.
Le Bouteiller P, Bensussan A. Le Bouteiller P, et al. Among authors: bensussan a. F1000Res. 2017 Jul 25;6:1216. doi: 10.12688/f1000research.11690.1. eCollection 2017. F1000Res. 2017. PMID: 28781765 Free PMC article. Review.
The Interleukin-17 Family of Cytokines in Breast Cancer.
Fabre JAS, Giustinniani J, Garbar C, Merrouche Y, Antonicelli F, Bensussan A. Fabre JAS, et al. Among authors: bensussan a. Int J Mol Sci. 2018 Dec 4;19(12):3880. doi: 10.3390/ijms19123880. Int J Mol Sci. 2018. PMID: 30518157 Free PMC article. Review.
[Immunopathology of psoriasis: from bench to bedside].
de Masson A, Bouaziz JD, Battistella M, Bagot M, Bensussan A. de Masson A, et al. Among authors: bensussan a. Med Sci (Paris). 2016 Mar;32(3):253-9. doi: 10.1051/medsci/20163203009. Epub 2016 Mar 23. Med Sci (Paris). 2016. PMID: 27011243 Free article. Review. French.
Atypical BRAF and NRAS Mutations in Mucosal Melanoma.
Dumaz N, Jouenne F, Delyon J, Mourah S, Bensussan A, Lebbé C. Dumaz N, et al. Among authors: bensussan a. Cancers (Basel). 2019 Aug 8;11(8):1133. doi: 10.3390/cancers11081133. Cancers (Basel). 2019. PMID: 31398831 Free PMC article. Review.
The human T-cell receptor.
Acuto O, Fabbi M, Bensussan A, Milanese C, Campen TJ, Royer HD, Reinherz EL. Acuto O, et al. Among authors: bensussan a. J Clin Immunol. 1985 May;5(3):141-57. doi: 10.1007/BF00915505. J Clin Immunol. 1985. PMID: 2409103 Review.
CD100 is a leukocyte semaphorin.
Delaire S, Elhabazi A, Bensussan A, Boumsell L. Delaire S, et al. Among authors: bensussan a. Cell Mol Life Sci. 1998 Nov;54(11):1265-76. doi: 10.1007/s000180050252. Cell Mol Life Sci. 1998. PMID: 9849618 Review.
[New developments in Sézary syndrome].
Caudron A, Marie-Cardine A, Bensussan A, Bagot M. Caudron A, et al. Among authors: bensussan a. Ann Dermatol Venereol. 2012 Jan;139(1):31-40. doi: 10.1016/j.annder.2011.09.188. Epub 2011 Nov 4. Ann Dermatol Venereol. 2012. PMID: 22225740 Review. French.
363 results